We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
72 hedge funds and large institutions have $99.3M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less funds holding
Funds holding: 76 → 72 (-4)
27% less capital invested
Capital invested by funds: $135M → $99.3M (-$36M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $632K
Holders
72
Holders Change
-4
Holders Change %
-5.26%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
21
Reduced
17
Closed
10
Calls
$3K
Puts
$632K
Net Calls
-$629K
Net Calls Change
-$877K
Top Buyers
Top Sellers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$6.92M |
| 2 |
TLCM
Tiger Legatus Capital Management
New York
|
-$4.15M |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$2.95M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$2.39M |
| 5 |
Renaissance Technologies
New York
|
-$1.35M |
